Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Limited produces and trades energetic pharmaceutical components or bulk drugs in India. Metronidazole (MTZ), 2 Methyl-5-Nitro Imidazole (2MNI), and Metronidazole Benzoate (MBO) are some of its major products. The firm also provides comprehensive range of goods for various business applications.

With its headquarters based in the commercial capital of India, Mumbai, Aarey Drugs & Pharmaceuticals Limited was integrated in 1990. Its major manufacturing unit is established in Tarapur, Maharashtra. On December 2006, the firm began the operational program for the inclusion of Tinidazole and Omidazole, two new products to its diverse product range. It is also looking forward in accelerating its production competence roughly by 50% to 50 M.T. of Metronidazole from the previous 35 M.T. and by 20 M.T. to the previous 10.5 M.T. of Metronidazole Benzoate.

Markets Covered

Aarey Drugs & Pharmaceuticals Ltd has its Headquarters in India and is commercially active in Asian and African Continents. Besides these two continents, the firm trades its products in the part of Europe and Australia.

Product Portfolio of Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd is the manufacturers, wholesalers, suppliers and dealers of business formulations & chemicals.

Product or Technology category(s) implemented by the firm are:

• API or chemicals
• Pharmaceuticals or Therapeutics
• Drug delivery

Remedial objectives of the firm are:

• Allergy
• Dermatology
• Infectious Diseases

APIs manufactured by the firm are:

• Metronidazol
• 2 Methyl -5-Nitro Imidazole
• Metronidazole Benzoate

Products offered by the firm are:

• Door Visors
• Industrial Chemicals
• Acrylic Finials
• Organic Chemicals
• Veterinary Bulk Drugs
• Chemicals

Chemicals offered by the firm are:

• Metronidazole
• Bulk Drugs
• Metrobenzoate
• Glaxzole
• Betapicolina
• Pharmaceutical Lotions
• Formic acid
• Benzene
• Methnol
• Toluene
• Ethyl Acetate
• Liquor Ammonia
• Butyl Acetate
• Glycerin
• Acetone
• MIBK
• Xylene
• IPA

The firm exports their products in various African nations and other nations such as Nepal, Germany, Sri Lanka and Pakistan. Aarey Drugs & Pharmaceuticals Ltd is taking various initiatives to set-up trade ties with other international countries as well.

Revenue

Aarey Drugs & Pharmaceuticals Ltd registered sales revenues of INR 121.0 million as on December 31, 2009. Other details of its earnings are mentioned below:

• Net income form sales - INR 260.5 million
• Operating profit before interest - INR 7.1 million,
• Revenues from everyday activities prior and post tax - INR 7.3 million
• Net profit - INR 7.3 million

In comparison to the 2009 statistics, its 2008 financial statement was as under:

• Net income form sales - INR 212.5 million
• Operating profit before interest - INR 7.6 million,
• Revenues from everyday activities prior and post tax - INR 7.6 million
• Net profit - INR 7.6 million

Future Initiatives

Aarey Drugs & Pharmaceuticals is looking forward to raise its company's capital via acquisition of rights, merits, debentures etc. It hopes to strengthen business relations with countries such as Germany, Pakistan, Sri Lanka and Nepal.